Spermidine has the best preclinical résumé of anything on this page — lifespan extension in yeast, flies, worms and mice, cardioprotection, and a clean autophagy mechanism. The human evidence is where it thins. SmartAge, a 12-month randomized trial in older adults with subjective cognitive decline, found no significant cognitive or biomarker benefit at the dose supplements use, with only exploratory signals. And a randomized pharmacokinetic study found high-dose spermidine supplementation did not raise plasma or salivary spermidine at all — it raised spermine.
Spermidine is a naturally occurring polyamine present in all human cells and obtained from the diet, with wheat germ, soybeans, aged cheese, mushrooms and other fermented or plant foods among the richest sources. It is a potent physiological inducer of autophagy, the cell's recycling and quality-control process, acting partly by inhibiting the acetyltransferase EP300 and promoting hypusination of the translation factor eIF5A. Endogenous spermidine levels decline with age, which has motivated interest in dietary supplementation, often from spermidine-rich wheat-germ extract, as a caloric-restriction mimetic to support healthy aging.
Claims below are supported by the primary sources linked under each line — the same sources we cite on the product page.
Each line pairs a claim that circulates in marketing and forums with the trial result that contradicts or narrows it.
Quotations are verbatim from the cited paper. Negative and inconclusive trials are listed alongside the positive ones because that is the whole point of this page.
“exploratory analyses indicated possible beneficial effects on verbal memory and inflammation”
Result: A total of 100 participants (51 in the spermidine group, 49 in the placebo group; mean age 69 years; 49% female) were included in the analysis. Over 12 months, no significant changes were observed in mnemonic discrimination performance (between-group difference, -0.03; 95% CI, -0.11 to 0.05; P = .47) or secondary outcomes. Exploratory…
Stated limitations: The study was a monocenter trial, and the dosage of spermidine (0.9 mg/d) might have been insufficient to elicit significant effects. The observed beneficial effects on verbal memory and inflammation were exploratory and require further validation.
“Compared with a placebo, spermidine supplementation significantly increased spermine levels in the plasma, but it did not affect spermidine or putrescine levels.”
“The intake of any polyamine was not significantly associated with all-cause or cause-specific mortality after controlling for covariates in men and women.”
“The difference in mortality risk between the highest and lowest spermidine intake was statistically comparable to being 5.7 years younger.”
Result: All-cause mortality (deaths per 1000 person-years) decreased across thirds of increasing spermidine intake from 40.5 to 23.7 and 15.1. The age-, sex-, and caloric intake-adjusted 20-year cumulative mortality incidence was 0.48, 0.41, and 0.38 for the lowest, middle, and highest thirds of spermidine intake, respectively. The age-, sex-,…
Stated limitations: The study design is observational, which means it can show correlation but not causation. While adjustments were made for various factors, unmeasured confounding cannot be entirely ruled out.
“Oral supplementation of the natural polyamine spermidine extends the lifespan of mice and exerts cardioprotective effects, reducing cardiac hypertrophy and preserving diastolic function.”
Result: Oral spermidine supplementation extended the lifespan of mice, reduced cardiac hypertrophy, and preserved diastolic function in old mice. It enhanced cardiac autophagy, mitophagy, mitochondrial respiration, and improved cardiomyocyte mechano-elastical properties, coinciding with increased titin phosphorylation and suppressed subclinical…
Stated limitations: The human data relies on correlations from food questionnaires, which may not establish causality. The study did not specify the exact doses of spermidine used in animal models or the specific dietary intake levels in humans.
In model organisms (yeast, worms, flies and mice) spermidine induces autophagy and extends lifespan, and in rodents it reduces age-related cardiac dysfunction and blood pressure and improves memory. Human evidence is earlier-stage and genuinely mixed. Prospective cohorts — Bruneck, NHANES, UK Biobank and Takayama — link higher dietary spermidine or polyamine intake to lower all-cause and cardiovascular mortality; in Bruneck, each 1-SD higher intake tracked with about a 26% lower hazard of death over 20 years, though such observational findings are confounded by overall diet quality and at least one large cohort found no association. Small trials report good tolerability (including wheat-germ extract), possible memory signals and, in one pilot, improved vaccine responses in older adults. Crucially, the most rigorous test to date — the 12-month SmartAge randomized trial at the 0.9 mg/day dose used in commercial supplements — found no benefit on its primary memory outcome or biomarkers, and a pharmacokinetic study found oral spermidine is largely converted to spermine, leaving dosing and bioavailability unsettled. Benefits beyond safe and mechanistically interesting remain unproven. This evidence describes the polyamine spermidine and its mechanisms (frequently delivered as wheat-germ extract in trials), not this specific commercial product.
A grade that cannot be falsified is a marketing claim. These are the specific results that would move this one up.
If you want spermidine, the dietary route has the epidemiology behind it and does not depend on the supplement bioavailability question: wheat germ, aged cheese, mushrooms, legumes. If you buy the extract, buy it knowing that the flagship 12-month trial at that dose was negative on its primary endpoint and that supplementation has not been shown to raise blood spermidine. Safety is genuinely good, which is why this stays listed.
The dietary route — which is where the human mortality epidemiology actually comes from.
Dose, wheat-germ standardisation and what the label numbers mean, if you are buying anyway.
Graded Strong. If you want an ingestible with settled human evidence, this is it.
Another compound where a superb animal literature has not translated into human outcomes.
Spermidine molecule page · Autophagy pathway · Can spermidine supplements improve longevity? · The SmartAge randomized trial, in full · The dietary spermidine mortality cohort, in full · The graded supplement guide
Sibling pages in this record: NMN (nicotinamide mononucleotide) · Resveratrol · Vitamin D · Omega-3 fish oil
Open Spermidine (Wheat-Germ Extract) in the Magellan store →
SmartAge randomized older adults with subjective cognitive decline to spermidine or placebo for 12 months. It did not find a significant benefit on its primary cognitive outcome. Exploratory analyses indicated possible beneficial effects on verbal memory and inflammation — exploratory findings from a trial that missed its primary endpoint are hypothesis-generating, not evidence of efficacy.
That is the right question and nobody has answered it. A randomized pharmacokinetic study found high-dose supplementation raised spermine but not spermidine in plasma or saliva. Possible explanations include gut metabolism, tissue-level effects not visible in blood, or the effect simply not being there. All three are live.
The cohort mortality data are large, prospective and directionally consistent across several populations, and safety is well established. Moderate is our label for several human studies pointing the same way with real limits — which is precisely this. The limits are stated on the product page and on this one.
The human mortality association comes from dietary intake, not from supplementation, so the dietary route is the one with the epidemiology behind it. It also sidesteps the bioavailability question entirely. Wheat germ is the densest common source.